JP Morgan Chase
AYTU icon

JP Morgan Chase’s AYTU BioPharma AYTU Stock Holding History

JP Morgan Chase’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$405 Buy
+154
New +$394 ﹤0.01% 7196
2025
Q1 		– Sell
-75
Closed -$125 – 7324
2024
Q4 		$125 Sell
75
-238
-76% -$435 ﹤0.01% 6980
2024
Q3 		$736 Sell
313
-227
-42% -$588 ﹤0.01% 6756
2024
Q2 		$1.57K Sell
540
-80
-13% -$241 ﹤0.01% 6553
2024
Q1 		$1.89K Sell
620
-6,215
-91% -$17.8K ﹤0.01% 6582
2023
Q4 		$19.4K Buy
6,835
+4,647
+212% +$12.8K ﹤0.01% 6256
2023
Q3 		$5.91K Buy
2,188
+1,601
+273% +$2.8K ﹤0.01% 6348
2023
Q2 		$939 Buy
+587
New +$1.15K ﹤0.01% 6463
2021
Q2 		– Sell
-2,769
Closed -$421K – 6333
2021
Q1 		$421K Buy
2,769
+2,392
+634% +$380K ﹤0.01% 4783
2020
Q4 		$45K Buy
377
+202
+115% +$36.8K ﹤0.01% 5177
2020
Q3 		$42K Buy
175
+70
+67% +$18K ﹤0.01% 4989
2020
Q2 		$30K Buy
+105
New +$31.8K ﹤0.01% 4965
2019
Q3 		– Sell
-62
Closed -$22K – 5712
2019
Q2 		$22K Buy
+62
New +$23.6K ﹤0.01% 5414

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's AYTU Position: Q1 2026 in Review

JP Morgan Chase opened a new position in AYTU BioPharma (AYTU) in Q1 2026: 154 shares worth $405. The stake represents ﹤0.01% of the portfolio and ranks #7196 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in AYTU as recently as Q4 2024.

JP Morgan Chase first reported a position in AYTU in Q2 2019 and has held it in 13 quarters since. The position peaked at $421K in Q1 2021. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • JP Morgan Chase held 154 shares of AYTU BioPharma worth $405 as of Q1 2026.
  • AYTU BioPharma was a new JP Morgan Chase position in Q1 2026.
  • AYTU BioPharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7196 holding.
  • JP Morgan Chase first reported a position in AYTU BioPharma in Q2 2019 and has held it in 13 quarters since.
  • JP Morgan Chase's AYTU BioPharma position peaked at $421K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.